These results, along with a earlier report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 support the notion of targeting ACKR3 as a novel method to modulate the opioid technique, which could open up new therapeutic avenues for opioid-relevant Problems. Disclaimer: The above mentioned is https://milesi036lhc5.blogpayz.com/profile